Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting

August 2, 2024

https://www.globenewswire.com/news-release/2024/08/01/2922716/0/en/Bionano-Announces-Presentation-of-Optical-Genome-Mapping-Utility-Across-Cancer-Research-Applications-at-the-Cancer-Genomics-Consortium-CGC-2024-Annual-Meeting.html

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) —

SAN DIEGO, August 1, 2024 (GLOBE NEWSWIRE) – Bionano Genomics, Inc. (Nasdaq:BNGO) today announced its participation at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting with a broad range of content covering the utility of optical genome mapping (OGM) for hematological malignancy cancer research, including scientific poster presentations and an exhibitor session featuring data from a multi-site study evaluating OGM’s utility for evaluating hematological malignancies.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.